Preventing heart failure in patients with diabetes
- PMID: 15331315
- DOI: 10.1016/j.mcna.2004.05.004
Preventing heart failure in patients with diabetes
Abstract
Diabetic cardiomyopathy is characterized by a prominent interstitial fibrosis. Postulated etiologies include microangiopathy, autonomic neuropathy, and metabolic factors. A common root of these pathologies is hyperglycemia or hyperinsulinemia, both of which are prominent in type 2 diabetes mellitus, which has the highest incidence of cardiovascular morbidity and mortality. The relative importance of each factor is a matter of debate; it is likely that both of these factors in addition to the concomitant risk factors seen in diabetics (dyslipidemias, hypertension, obesity, coagulation abnormalities) contribute to the spectrum of myocardial disease in diabetes. A discussion of these contributive pathologies and the hyperglycemia and hyperinsulinemia that underlie them is the subject of this review. Treatment methodologies to control the development of such pathology also are discussed.
Similar articles
-
Hyperinsulinemia and cardiovascular risk.Heart Lung. 1994 Mar-Apr;23(2):118-22; 123-4. Heart Lung. 1994. PMID: 8206768 Review.
-
Coronary artery disease and prevention of heart failure.Med Clin North Am. 2004 Sep;88(5):1209-35. doi: 10.1016/j.mcna.2004.03.002. Med Clin North Am. 2004. PMID: 15331314 Review.
-
Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.Am J Manag Care. 2002 Oct;8(16 Suppl):S450-9. Am J Manag Care. 2002. PMID: 12408408 Review.
-
Optimal medical treatment of cardiovascular risk factors: can we prevent the development of heart failure?Expert Rev Cardiovasc Ther. 2009 Feb;7(2):147-57. doi: 10.1586/14779072.7.2.147. Expert Rev Cardiovasc Ther. 2009. PMID: 19210211 Review.
-
[Risk factors for atherosclerosis in non-insulin-dependent diabetes].Journ Annu Diabetol Hotel Dieu. 1992:101-12. Journ Annu Diabetol Hotel Dieu. 1992. PMID: 1495229 Review. French. No abstract available.
Cited by
-
Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus.J Nucl Cardiol. 2006 Jan-Feb;13(1):34-42. doi: 10.1016/j.nuclcard.2005.11.009. J Nucl Cardiol. 2006. PMID: 16464715 Clinical Trial.
-
Beneficial Effect of 7-O-Galloyl-D-sedoheptulose, a Polyphenol Isolated from Corni Fructus, against Diabetes-Induced Alterations in Kidney and Adipose Tissue of Type 2 Diabetic db/db Mice.Evid Based Complement Alternat Med. 2013;2013:736856. doi: 10.1155/2013/736856. Epub 2013 Nov 20. Evid Based Complement Alternat Med. 2013. PMID: 24348717 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical